Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Guidelines for Sinusitis Agreed to by Allergists, Otolaryngologist - Head and Neck Surgeons

07.12.2004


Rhinosinusitis, the inflammation of the mucous membrane of the nose and sinuses, has increased in both prevalence and incidence. Health officials believe that this disorder, also known as sinusitis, causes significant physical symptoms, negatively affects quality of life, and can substantially impair daily functions. It is now estimated that rhinosinusitis affects approximately 31 million Americans each year.



Recognizing a need for evidence-based rhinosinusitis guidelines, five national societies,The American Academy of Allergy, Asthma and Immunology (AAAAI); The American Academy of Otolaryngic Allergy; The American Academy of Otolaryngology -- Head and Neck Surgery (AAO-HNS); The American College of Allergy, Asthma and Immunology; and the American Rhinologic Society convened a panel of 30 physicians from a wide range of disciplines to develop definitions of rhinosinusitis for clinical research, and suggest clinical trial designs for studies that would allow for more appropriate use of pharmacologic, immunologic, and surgical interventions.

For the clinician, existing definitions of the disease fail to describe all manifestations of rhinosinusitis. This is due, in part, to the numerous causes of rhinosinusitis, which can be viral, bacterial, fungal, allergic, and for some patients, of unknown origin. Rhinosinusitis can be acute or chronic (the latter defined by the Sinus and Allergy Health Partnership as “a group of disorders characterized by inflammation of the mucosa of the nose and paranasal sinuses of at least 12 weeks’ duration." (Otolaryngology Head and Neck Surgery, September 2003)). Other classes i.e., subacute, recurrent acute, acute exacerbation of chronic, community acquired bacterial, and nosocomial, have been used in medical literature.


“We believed that the lack of a consensus definition for chronic rhinosinusitis hampered efforts to conduct research studies or to attempt studies of medical treatment,” agreed Eli O. Meltzer, MD, a member of the AAAAI’s Sinusitis Committee and James Hadley, MD, Past President of both the AAOA and ARS.

Their findings are provided in a supplement, “Rhinosinusitis: Establishing Definitions for Clinical Research and Patient Care,” published concurrently in the December 2004 editions of the Journal of Allergy & Clinical Immunology (JACI) http://www.mosby.com/jaci/ and Otolaryngology – Head and Neck Surgery (OTO-HNS) http://www.mosby.com/oto/. The corresponding author is Eli O. Meltzer, MD, Co-Director, Allergy and Asthma Medical Group and Research Center, San Diego, CA.

Findings: After two days of meeting, this panel was able to reach consensus (more than 80 percent of committee members) on definitions and clinical research strategies for acute (bacterial) rhinosinusitis, chronic rhinosinusitis without polyps, chronic rhinosinusitis with polyps, and allergic fungal rhinosinusitis. Other conclusions reached were:

* No one etiologic factor fully explains or adequately accounts for the pathologic manifestations and clinical differences found in rhinosinusitis. The inflammatory component of these disorders manifests as a mixed mononuclear inflammatory cell infiltrate with neutrophils predominating in acute disease and eosinophils predominating in most chronic disease.

* Chronic rhinosinusitis has a significant inflammatory component that may be caused simultaneously or independently by various factors. These include but are not restricted to the possible roles of: persistent infection as a factor in chronic rhinosinusitis including biofilms and “osteitis” (inflammation of the bone); allergy and other disorders of immunity; intrinsic factors of the upper airway; super antigens from Staphylococcus aureus in chronic rhinosinusitis with nasal polyps; colonizing fungi that induce and sustain eosinophilic inflammation; and metabolic perturbations such as aspirin sensitivity.

The panel agreed on consensus definitions for rhinosinusitis as applied to (1) acute presumed bacterial rhinosinusitis; (2) chronic rhinosinusitis without polyps; (3) chronic rhinosinusitis with polyps; and (4) classic allergic fungal rhinosinusitis. Additionally, initial proposals were made for clinical trial designs, including an outline of suggested subjective and objective assessments applicable to these studies.

Conclusions: The definitions and guidelines outlined in “Rhinosinusitis: Establishing Definitions for Clinical Research and Patient Care,” will be invaluable to physicians who diagnose and treat sinusitis and the clinicians and researchers responsible for developing and implementing appropriate clinical studies.

The work of this important consensus panel will serve as a catalyst for further research of this debilitating disorder. But the participants in this effort agree that 1) promoting more research on both acute and chronic rhinosinusitis is essential; 2) a better understanding of the cause of these diseases is needed; 3) study designs for the evaluation of potential therapeutic modalities for rhinosinusitis, as well as appropriate outcome studies must be carefully considered.

The AAAAI is the largest professional medical specialty organization in the United States representing allergists, asthma specialists, clinical immunologists, allied health professionals and others with a special interest in the research and treatment of allergic disease. Allergy/immunology specialists are pediatric or internal medicine physicians who have elected an additional two years of training to become specialized in the treatment of asthma, allergy and immunologic disease. Established in 1943, the AAAAI has nearly 6,000 members in the United States, Canada and 60 other countries. The AAAAI serves as an advocate to the public by providing educational information through its Web site at http://www.aaaai.org.

The American Academy of Otolaryngology – Head and Neck Surgery http://www.entnet.org, one of the oldest medical associations in the nation, represents more than 10,000 physicians and allied health professionals who specialize in the diagnosis and treatment of disorders of the ears, nose, throat, and related structures of the head and neck. The Academy serves its members by facilitating the advancement of the science and art of medicine related to otolaryngology and by representing the specialty in governmental and socioeconomic issues. The organization’s mission is: “Working for the Best Ear, Nose, and Throat Care.”

| newswise
Further information:
http://www.aaaai.org
http://www.entnet.org

More articles from Health and Medicine:

nachricht Collagen nanofibrils in mammalian tissues get stronger with exercise
14.12.2018 | University of Illinois College of Engineering

nachricht New discoveries predict ability to forecast dementia from single molecule
12.12.2018 | UT Southwestern Medical Center

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Data use draining your battery? Tiny device to speed up memory while also saving power

The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.

Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...

Im Focus: An energy-efficient way to stay warm: Sew high-tech heating patches to your clothes

Personal patches could reduce energy waste in buildings, Rutgers-led study says

What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...

Im Focus: Lethal combination: Drug cocktail turns off the juice to cancer cells

A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.

The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...

Im Focus: New Foldable Drone Flies through Narrow Holes in Rescue Missions

A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.

Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...

Im Focus: Topological material switched off and on for the first time

Key advance for future topological transistors

Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

ICTM Conference 2019: Digitization emerges as an engineering trend for turbomachinery construction

12.12.2018 | Event News

New Plastics Economy Investor Forum - Meeting Point for Innovations

10.12.2018 | Event News

EGU 2019 meeting: Media registration now open

06.12.2018 | Event News

 
Latest News

Data use draining your battery? Tiny device to speed up memory while also saving power

14.12.2018 | Power and Electrical Engineering

Tangled magnetic fields power cosmic particle accelerators

14.12.2018 | Physics and Astronomy

In search of missing worlds, Hubble finds a fast evaporating exoplanet

14.12.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>